Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
2(20%)
Results Posted
33%(2 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_2
5
50%
Ph phase_4
1
10%
Ph phase_3
4
40%

Phase Distribution

0

Early Stage

5

Mid Stage

5

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
5(50.0%)
Phase 3Large-scale testing
4(40.0%)
Phase 4Post-market surveillance
1(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(6)
Terminated(1)
Other(1)

Detailed Status

Completed6
Recruiting2
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 25 (50.0%)
Phase 34 (40.0%)
Phase 41 (10.0%)

Trials by Status

unknown110%
completed660%
terminated110%
recruiting220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10